Join me in my adventures as I explore hidden gems, lost secrets, and forgotten relics tucked away all over America, and ...

GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced ... according to professor Mark Lawler, a cancer research ...

The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight loss in a 72-week trial than Wegovy (semaglutide). Participants taking Zepbound lost 50 pounds (lb) on average ...

Kayla Girgen, RD, is a licensed dietitian who specializes in weight management and weight loss for patients after bariatric surgery. Water is the most abundant component in the body and is ...

This Is Us' star Chrissy Metz debuted her 100 lb. weight loss in May 2025 Jeffrey Mayer/WireImage ; Leah Puttkammer/FilmMagic Chrissy Metz is opening up about her health journey. Metz — who rose ...

Share on Pinterest Time-restricted eating may help sustain weight loss results in the long term ... At the 12-month mark after the study’s conclusion, Camacho-Cardenosa and her team found ...

After fans took notice of her new appearance, Trainor addressed her significant weight loss on Instagram, attributing her transformation to "huge lifestyle changes" such as using the weight-loss ...

“We have learned over the past 20-odd years that in order to overcome plateau phenomenon in obesity, if you can add mechanisms that are completely different together, you can often get additional ...

A major 72-week trial shows tirzepatide leads to double-digit weight loss and greater waist reduction than semaglutide, reshaping obesity treatment strategies and offering new hope for patients ...

Some people with hyperparathyroidism may notice weight gain or weight loss. These changes may occur due to factors like underlying medical conditions or appetite changes. Hyperparathyroidism is ...

Deciding which jab to nab? When it comes to shedding pounds and cinching inches, a new study puts one weight loss drug ahead of another. Published in the New England Journal of Medicine ...